Seres Therapeutics公司今日宣布了其研发管线及企业运营的最新进展,并明确将炎症与免疫疾病领域的新兴治疗项目作为未来发展的战略重点。公司表示,此举旨在集中资源推进具有高潜力的创新疗法,以应对当前未满足的临床需求。
Seres Therapeutics公司今日宣布了其研发管线及企业运营的最新进展,并明确将炎症与免疫疾病领域的新兴治疗项目作为未来发展的战略重点。公司表示,此举旨在集中资源推进具有高潜力的创新疗法,以应对当前未满足的临床需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.